- Home
- Publications
- Publication Search
- Publication Details
Title
Drug therapy for osteoporosis in older adults
Authors
Keywords
-
Journal
LANCET
Volume 399, Issue 10329, Pages 1080-1092
Publisher
Elsevier BV
Online
2022-03-11
DOI
10.1016/s0140-6736(21)02646-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
- (2021) E. Söreskog et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA‐HD Study Extension
- (2021) Sabashini K Ramchand et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
- (2021) Peter Burckhardt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2‐Year Randomized Study
- (2021) Anne Sophie Sølling et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05
- (2021) H. Hagino et al. OSTEOPOROSIS INTERNATIONAL
- Multiple vertebral fractures after suspension of denosumab. A series of 56 cases
- (2021) Manuel Sosa‐Henríquez et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Patient Outcomes in the Years After a DXA‐BMD Treatment Monitoring Test: Improved Medication Adherence in Some, But Too Little Too Late
- (2021) Gregory A Kline et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Increased fracture risk after discontinuation of anti‐osteoporosis medications among hip fracture patients: A population‐based cohort study
- (2021) Shau‐Huai Fu et al. JOURNAL OF INTERNAL MEDICINE
- Nutritional intake and bone health
- (2021) René Rizzoli et al. Lancet Diabetes & Endocrinology
- Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial
- (2020) Andrew Grey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk
- (2020) Jeffrey R. Curtis et al. MEDICAL CARE
- A broader strategy for osteoporosis interventions
- (2020) Ian R. Reid Nature Reviews Endocrinology
- Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
- (2020) Sarah Davis et al. HEALTH TECHNOLOGY ASSESSMENT
- A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
- (2020) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture
- (2020) James R. Turk et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials
- (2020) Dennis M Black et al. Lancet Diabetes & Endocrinology
- Randomized Trial Evaluation of Benefits and Risks of Menopausal Hormone Therapy Among Women Aged 50-59
- (2020) Ross L Prentice et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Predictors of Fracture in Older Women With Osteopenic Hip Bone Mineral Density Treated With Zoledronate
- (2020) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15‐Year US Postmarketing Surveillance Study
- (2020) Alicia Gilsenan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS
- (2020) Elena Tsourdi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
- (2020) Pieter Evenepoel et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
- (2020) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of oral bisphosphonates in moderate‐to‐severe chronic kidney disease: a bi‐national cohort analysis
- (2020) Danielle E. Robinson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Risk factors for vertebral fractures and bone loss after denosumab discontinuation: A real-world observational study
- (2020) J. Everts-Graber et al. BONE
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women
- (2019) Sarah M Bristow et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Performance of FRAX and FRAX‐Based Treatment Thresholds in Women Aged 40 and Older: The Manitoba BMD Registry
- (2019) Carolyn J. Crandall et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bazedoxifene for the treatment of osteoporosis
- (2019) Maria P. Yavropoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study
- (2019) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment
- (2019) Pascale Chavassieux et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength
- (2019) Lauren A. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Standard vs Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial
- (2019) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Controversies in medicine: the role of calcium and vitamin D supplements in adults
- (2019) Ian R Reid et al. MEDICAL JOURNAL OF AUSTRALIA
- Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
- (2019) D.L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial
- (2019) Joy N Tsai et al. Lancet Diabetes & Endocrinology
- Physical activity and skeletal health in adults
- (2019) Jane A Cauley et al. Lancet Diabetes & Endocrinology
- Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
- (2019) T. Merlijn et al. OSTEOPOROSIS INTERNATIONAL
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study
- (2018) Annette L Adams et al. JOURNAL OF BONE AND MINERAL RESEARCH
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
- (2018) E Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density
- (2018) K. E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis
- (2018) Adolfo Díez-Pérez et al. BONE
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
- (2018) E Michael Lewiecki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fracture Prevention with Zoledronate in Older Women with Osteopenia
- (2018) Ian R. Reid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials
- (2018) S. Lou et al. OSTEOPOROSIS INTERNATIONAL
- Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults
- (2017) Jia-Guo Zhao et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparisons of Interventions for Preventing Falls in Older Adults
- (2017) Andrea C. Tricco et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: A randomized clinical trial
- (2017) Lynette M. Smith et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users
- (2017) P. A. Eiken et al. OSTEOPOROSIS INTERNATIONAL
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study
- (2017) Robert Scragg et al. JAMA Cardiology
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline
- (2016) Heike A. Bischoff-Ferrari et al. JAMA Internal Medicine
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
- (2015) K. E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
- (2014) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population
- (2014) T.-C. Lin et al. OSTEOPOROSIS INTERNATIONAL
- Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2013) Adolfo Díez-Pérez et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin: Another Vascular Calcification Inhibitor?
- (2013) Kathleen J. Claes et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Incidence of Acute Anterior Uveitis after Intravenous Zoledronate
- (2013) Dipika V. Patel et al. OPHTHALMOLOGY
- Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
- (2012) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A systematic review of hip fracture incidence and probability of fracture worldwide
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women
- (2010) Kerrie M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent
- (2009) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*
- (2008) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Retreatment With Teriparatide One Year After the First Teriparatide Course in Patients on Continued Long-Term Alendronate
- (2008) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effects of Tibolone in Older Postmenopausal Women
- (2008) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effective osteoporosis treatment thresholds: the United States perspective
- (2008) A. N. A. Tosteson et al. OSTEOPOROSIS INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started